Dendreon Corporation Announces Data Presentation at the 2012 American Urological Association Annual Meeting

SEATTLE--(BUSINESS WIRE)-- May 21, 2012–Dendreon Corporation (NASDAQ: DNDN) today announced the following PROVENGE® (sipuleucel-T) data will be presented at the American Urological Association (AUA) Annual Meeting taking place May 19 – 23, 2012 in Atlanta, Georgia.

Back to news